Surgery Partners received a non-binding offer from Bain Capital to acquire the rest of the company, valued at $3.25 billion. Read more about the M&A activity.
Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY – Research Report), with a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback